BD biosciences - clontech:1109645 [15-048418]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201500395P
Awardee
Awarding agency
Obligated
$161,406

Award facts

Contract value 100% obligated
$161,406.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20814, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · To DE-obligate funds from FY2018 expiring lines in accordance with NIH oalm communication 23-18 -$4,752
Other Administrative Action P00007 · This modification enables the transition from the NIH office of financial management (OFM) electronic invoice submission system to the department of… $0
Exercise an Option P00006 · To exercise option year four $34,182
Exercise an Option 5 · Service contract for DB BIO-sciences, exercise option year 3 $34,182
Exercise an Option 4 $34,182
Other Administrative Action 3 · Service contract for BD biosciences, facsaria special order flow cytometry cell sorter; sapphire 488-100 blue laser, cohr 640-40 red laser, genesis 355-60 UV… $0
Exercise an Option 2 $29,430
Other Administrative Action 1 · BD biosciences - coverage includes the BD facsaria special order system, s/n P46900083, with one computer workstation. Two prevent -- catalog # : 345382; SVC… $4,752
Original award $29,430

About this award

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for $161,406.02. The contract is for BD Biosciences, a division of BD, to provide specialized equipment, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies.

BD is a global medical technology company that has extensive experience providing a wide range of goods and services to U.S. government agencies, including the Department of Veterans Affairs, NIH, and Department of Defense. This contract is not designated as a set-aside. BD also holds various indefinite delivery/indefinite quantity (IDIQ) contract vehicles with federal agencies that facilitate simplified ordering of its products, including with the NIH and VA, which can extend through 2028. The contract award indicates BD's continued role as a major supplier of specialized equipment and consumables for laboratory and biomedical research applications across the federal government.

Quick answers

Who was awarded contract HHSN261201500395P?

HHSN261201500395P was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on September 25, 2015.

How much is contract HHSN261201500395P worth?

The government has obligated $161,406 on HHSN261201500395P.

Was contract HHSN261201500395P competed?

The extent of competition for HHSN261201500395P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award